Global Covid-19 Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 113

Published Date: 18 Mar 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Patients today have more treatment options in the battle against coronavirus disease.

In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.

The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.

The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.

In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.

In this report, we study all treatment method for Covid-19.

According to our (Global Info Research) latest study, the global Covid-19 Treatment market size was valued at USD 14310 million in 2022 and is forecast to a readjusted size of USD 41 million by 2029 with a CAGR of -56.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.

This report is a detailed and comprehensive analysis for global Covid-19 Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Covid-19 Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Covid-19 Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Covid-19 Treatment market size and forecasts, by Type and by End User, in consumption value ($ Million), 2018-2029
Global Covid-19 Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Covid-19 Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Covid-19 Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis and AstraZeneca, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Covid-19 Treatment market is split by Type and by End User. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Life Support
    Antiviral Medicine
    Antibody Treatments
    Others

Market segment by End User
    Children
    Adult

Market segment by players, this report covers
    Cadila Healthcare
    Johnson & Johnson
    ImmunoPrecise
    Novartis
    AstraZeneca
    Cipla
    AbbVie
    Bayer
    Regeneron Pharmaceuticals
    Ascletis Pharma
    GlaxoSmithKline
    Gilead Sciences
    Pharmstandard
    Fujifilm Holdings
    Zhejiang Hisun Pharmaceutical Co. Ltd
    Roche
    Sanofi
    Pfizer
    Eli Lilly

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Covid-19 Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Covid-19 Treatment, with revenue, gross margin and global market share of Covid-19 Treatment from 2018 to 2023.
Chapter 3, the Covid-19 Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Covid-19 Treatment market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Covid-19 Treatment.
Chapter 13, to describe Covid-19 Treatment research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Covid-19 Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Covid-19 Treatment by Type
        1.3.1 Overview: Global Covid-19 Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Covid-19 Treatment Consumption Value Market Share by Type in 2022
        1.3.3 Life Support
        1.3.4 Antiviral Medicine
        1.3.5 Antibody Treatments
        1.3.6 Others
    1.4 Global Covid-19 Treatment Market by End User
        1.4.1 Overview: Global Covid-19 Treatment Market Size by End User: 2018 Versus 2022 Versus 2029
        1.4.2 Children
        1.4.3 Adult
    1.5 Global Covid-19 Treatment Market Size & Forecast
    1.6 Global Covid-19 Treatment Market Size and Forecast by Region
        1.6.1 Global Covid-19 Treatment Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Covid-19 Treatment Market Size by Region, (2018-2029)
        1.6.3 North America Covid-19 Treatment Market Size and Prospect (2018-2029)
        1.6.4 Europe Covid-19 Treatment Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Covid-19 Treatment Market Size and Prospect (2018-2029)
        1.6.6 South America Covid-19 Treatment Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Covid-19 Treatment Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Cadila Healthcare
        2.1.1 Cadila Healthcare Details
        2.1.2 Cadila Healthcare Major Business
        2.1.3 Cadila Healthcare Covid-19 Treatment Product and Solutions
        2.1.4 Cadila Healthcare Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Cadila Healthcare Recent Developments and Future Plans
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Covid-19 Treatment Product and Solutions
        2.2.4 Johnson & Johnson Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Johnson & Johnson Recent Developments and Future Plans
    2.3 ImmunoPrecise
        2.3.1 ImmunoPrecise Details
        2.3.2 ImmunoPrecise Major Business
        2.3.3 ImmunoPrecise Covid-19 Treatment Product and Solutions
        2.3.4 ImmunoPrecise Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 ImmunoPrecise Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Covid-19 Treatment Product and Solutions
        2.4.4 Novartis Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Covid-19 Treatment Product and Solutions
        2.5.4 AstraZeneca Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 AstraZeneca Recent Developments and Future Plans
    2.6 Cipla
        2.6.1 Cipla Details
        2.6.2 Cipla Major Business
        2.6.3 Cipla Covid-19 Treatment Product and Solutions
        2.6.4 Cipla Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Cipla Recent Developments and Future Plans
    2.7 AbbVie
        2.7.1 AbbVie Details
        2.7.2 AbbVie Major Business
        2.7.3 AbbVie Covid-19 Treatment Product and Solutions
        2.7.4 AbbVie Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 AbbVie Recent Developments and Future Plans
    2.8 Bayer
        2.8.1 Bayer Details
        2.8.2 Bayer Major Business
        2.8.3 Bayer Covid-19 Treatment Product and Solutions
        2.8.4 Bayer Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Bayer Recent Developments and Future Plans
    2.9 Regeneron Pharmaceuticals
        2.9.1 Regeneron Pharmaceuticals Details
        2.9.2 Regeneron Pharmaceuticals Major Business
        2.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Product and Solutions
        2.9.4 Regeneron Pharmaceuticals Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
    2.10 Ascletis Pharma
        2.10.1 Ascletis Pharma Details
        2.10.2 Ascletis Pharma Major Business
        2.10.3 Ascletis Pharma Covid-19 Treatment Product and Solutions
        2.10.4 Ascletis Pharma Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Ascletis Pharma Recent Developments and Future Plans
    2.11 GlaxoSmithKline
        2.11.1 GlaxoSmithKline Details
        2.11.2 GlaxoSmithKline Major Business
        2.11.3 GlaxoSmithKline Covid-19 Treatment Product and Solutions
        2.11.4 GlaxoSmithKline Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 GlaxoSmithKline Recent Developments and Future Plans
    2.12 Gilead Sciences
        2.12.1 Gilead Sciences Details
        2.12.2 Gilead Sciences Major Business
        2.12.3 Gilead Sciences Covid-19 Treatment Product and Solutions
        2.12.4 Gilead Sciences Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Gilead Sciences Recent Developments and Future Plans
    2.13 Pharmstandard
        2.13.1 Pharmstandard Details
        2.13.2 Pharmstandard Major Business
        2.13.3 Pharmstandard Covid-19 Treatment Product and Solutions
        2.13.4 Pharmstandard Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Pharmstandard Recent Developments and Future Plans
    2.14 Fujifilm Holdings
        2.14.1 Fujifilm Holdings Details
        2.14.2 Fujifilm Holdings Major Business
        2.14.3 Fujifilm Holdings Covid-19 Treatment Product and Solutions
        2.14.4 Fujifilm Holdings Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Fujifilm Holdings Recent Developments and Future Plans
    2.15 Zhejiang Hisun Pharmaceutical Co. Ltd
        2.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Details
        2.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
        2.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product and Solutions
        2.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
    2.16 Roche
        2.16.1 Roche Details
        2.16.2 Roche Major Business
        2.16.3 Roche Covid-19 Treatment Product and Solutions
        2.16.4 Roche Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Roche Recent Developments and Future Plans
    2.17 Sanofi
        2.17.1 Sanofi Details
        2.17.2 Sanofi Major Business
        2.17.3 Sanofi Covid-19 Treatment Product and Solutions
        2.17.4 Sanofi Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Sanofi Recent Developments and Future Plans
    2.18 Pfizer
        2.18.1 Pfizer Details
        2.18.2 Pfizer Major Business
        2.18.3 Pfizer Covid-19 Treatment Product and Solutions
        2.18.4 Pfizer Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Pfizer Recent Developments and Future Plans
    2.19 Eli Lilly
        2.19.1 Eli Lilly Details
        2.19.2 Eli Lilly Major Business
        2.19.3 Eli Lilly Covid-19 Treatment Product and Solutions
        2.19.4 Eli Lilly Covid-19 Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 Eli Lilly Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Covid-19 Treatment Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Covid-19 Treatment by Company Revenue
        3.2.2 Top 3 Covid-19 Treatment Players Market Share in 2022
        3.2.3 Top 6 Covid-19 Treatment Players Market Share in 2022
    3.3 Covid-19 Treatment Market: Overall Company Footprint Analysis
        3.3.1 Covid-19 Treatment Market: Region Footprint
        3.3.2 Covid-19 Treatment Market: Company Product Type Footprint
        3.3.3 Covid-19 Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Covid-19 Treatment Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Covid-19 Treatment Market Forecast by Type (2024-2029)

5 Market Size Segment by End User
    5.1 Global Covid-19 Treatment Consumption Value Market Share by End User (2018-2023)
    5.2 Global Covid-19 Treatment Market Forecast by End User (2024-2029)

6 North America
    6.1 North America Covid-19 Treatment Consumption Value by Type (2018-2029)
    6.2 North America Covid-19 Treatment Consumption Value by End User (2018-2029)
    6.3 North America Covid-19 Treatment Market Size by Country
        6.3.1 North America Covid-19 Treatment Consumption Value by Country (2018-2029)
        6.3.2 United States Covid-19 Treatment Market Size and Forecast (2018-2029)
        6.3.3 Canada Covid-19 Treatment Market Size and Forecast (2018-2029)
        6.3.4 Mexico Covid-19 Treatment Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Covid-19 Treatment Consumption Value by Type (2018-2029)
    7.2 Europe Covid-19 Treatment Consumption Value by End User (2018-2029)
    7.3 Europe Covid-19 Treatment Market Size by Country
        7.3.1 Europe Covid-19 Treatment Consumption Value by Country (2018-2029)
        7.3.2 Germany Covid-19 Treatment Market Size and Forecast (2018-2029)
        7.3.3 France Covid-19 Treatment Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Covid-19 Treatment Market Size and Forecast (2018-2029)
        7.3.5 Russia Covid-19 Treatment Market Size and Forecast (2018-2029)
        7.3.6 Italy Covid-19 Treatment Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Covid-19 Treatment Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Covid-19 Treatment Consumption Value by End User (2018-2029)
    8.3 Asia-Pacific Covid-19 Treatment Market Size by Region
        8.3.1 Asia-Pacific Covid-19 Treatment Consumption Value by Region (2018-2029)
        8.3.2 China Covid-19 Treatment Market Size and Forecast (2018-2029)
        8.3.3 Japan Covid-19 Treatment Market Size and Forecast (2018-2029)
        8.3.4 South Korea Covid-19 Treatment Market Size and Forecast (2018-2029)
        8.3.5 India Covid-19 Treatment Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Covid-19 Treatment Market Size and Forecast (2018-2029)
        8.3.7 Australia Covid-19 Treatment Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Covid-19 Treatment Consumption Value by Type (2018-2029)
    9.2 South America Covid-19 Treatment Consumption Value by End User (2018-2029)
    9.3 South America Covid-19 Treatment Market Size by Country
        9.3.1 South America Covid-19 Treatment Consumption Value by Country (2018-2029)
        9.3.2 Brazil Covid-19 Treatment Market Size and Forecast (2018-2029)
        9.3.3 Argentina Covid-19 Treatment Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Covid-19 Treatment Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Covid-19 Treatment Consumption Value by End User (2018-2029)
    10.3 Middle East & Africa Covid-19 Treatment Market Size by Country
        10.3.1 Middle East & Africa Covid-19 Treatment Consumption Value by Country (2018-2029)
        10.3.2 Turkey Covid-19 Treatment Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Covid-19 Treatment Market Size and Forecast (2018-2029)
        10.3.4 UAE Covid-19 Treatment Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Covid-19 Treatment Market Drivers
    11.2 Covid-19 Treatment Market Restraints
    11.3 Covid-19 Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Covid-19 Treatment Industry Chain
    12.2 Covid-19 Treatment Upstream Analysis
    12.3 Covid-19 Treatment Midstream Analysis
    12.4 Covid-19 Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Covid-19 Treatment Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Covid-19 Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Covid-19 Treatment Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Cadila Healthcare Company Information, Head Office, and Major Competitors
    Table 6. Cadila Healthcare Major Business
    Table 7. Cadila Healthcare Covid-19 Treatment Product and Solutions
    Table 8. Cadila Healthcare Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Cadila Healthcare Recent Developments and Future Plans
    Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 11. Johnson & Johnson Major Business
    Table 12. Johnson & Johnson Covid-19 Treatment Product and Solutions
    Table 13. Johnson & Johnson Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Johnson & Johnson Recent Developments and Future Plans
    Table 15. ImmunoPrecise Company Information, Head Office, and Major Competitors
    Table 16. ImmunoPrecise Major Business
    Table 17. ImmunoPrecise Covid-19 Treatment Product and Solutions
    Table 18. ImmunoPrecise Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. ImmunoPrecise Recent Developments and Future Plans
    Table 20. Novartis Company Information, Head Office, and Major Competitors
    Table 21. Novartis Major Business
    Table 22. Novartis Covid-19 Treatment Product and Solutions
    Table 23. Novartis Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Novartis Recent Developments and Future Plans
    Table 25. AstraZeneca Company Information, Head Office, and Major Competitors
    Table 26. AstraZeneca Major Business
    Table 27. AstraZeneca Covid-19 Treatment Product and Solutions
    Table 28. AstraZeneca Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. AstraZeneca Recent Developments and Future Plans
    Table 30. Cipla Company Information, Head Office, and Major Competitors
    Table 31. Cipla Major Business
    Table 32. Cipla Covid-19 Treatment Product and Solutions
    Table 33. Cipla Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Cipla Recent Developments and Future Plans
    Table 35. AbbVie Company Information, Head Office, and Major Competitors
    Table 36. AbbVie Major Business
    Table 37. AbbVie Covid-19 Treatment Product and Solutions
    Table 38. AbbVie Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. AbbVie Recent Developments and Future Plans
    Table 40. Bayer Company Information, Head Office, and Major Competitors
    Table 41. Bayer Major Business
    Table 42. Bayer Covid-19 Treatment Product and Solutions
    Table 43. Bayer Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Bayer Recent Developments and Future Plans
    Table 45. Regeneron Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 46. Regeneron Pharmaceuticals Major Business
    Table 47. Regeneron Pharmaceuticals Covid-19 Treatment Product and Solutions
    Table 48. Regeneron Pharmaceuticals Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Regeneron Pharmaceuticals Recent Developments and Future Plans
    Table 50. Ascletis Pharma Company Information, Head Office, and Major Competitors
    Table 51. Ascletis Pharma Major Business
    Table 52. Ascletis Pharma Covid-19 Treatment Product and Solutions
    Table 53. Ascletis Pharma Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Ascletis Pharma Recent Developments and Future Plans
    Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 56. GlaxoSmithKline Major Business
    Table 57. GlaxoSmithKline Covid-19 Treatment Product and Solutions
    Table 58. GlaxoSmithKline Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. GlaxoSmithKline Recent Developments and Future Plans
    Table 60. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 61. Gilead Sciences Major Business
    Table 62. Gilead Sciences Covid-19 Treatment Product and Solutions
    Table 63. Gilead Sciences Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Gilead Sciences Recent Developments and Future Plans
    Table 65. Pharmstandard Company Information, Head Office, and Major Competitors
    Table 66. Pharmstandard Major Business
    Table 67. Pharmstandard Covid-19 Treatment Product and Solutions
    Table 68. Pharmstandard Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Pharmstandard Recent Developments and Future Plans
    Table 70. Fujifilm Holdings Company Information, Head Office, and Major Competitors
    Table 71. Fujifilm Holdings Major Business
    Table 72. Fujifilm Holdings Covid-19 Treatment Product and Solutions
    Table 73. Fujifilm Holdings Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Fujifilm Holdings Recent Developments and Future Plans
    Table 75. Zhejiang Hisun Pharmaceutical Co. Ltd Company Information, Head Office, and Major Competitors
    Table 76. Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
    Table 77. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product and Solutions
    Table 78. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
    Table 80. Roche Company Information, Head Office, and Major Competitors
    Table 81. Roche Major Business
    Table 82. Roche Covid-19 Treatment Product and Solutions
    Table 83. Roche Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Roche Recent Developments and Future Plans
    Table 85. Sanofi Company Information, Head Office, and Major Competitors
    Table 86. Sanofi Major Business
    Table 87. Sanofi Covid-19 Treatment Product and Solutions
    Table 88. Sanofi Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Sanofi Recent Developments and Future Plans
    Table 90. Pfizer Company Information, Head Office, and Major Competitors
    Table 91. Pfizer Major Business
    Table 92. Pfizer Covid-19 Treatment Product and Solutions
    Table 93. Pfizer Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Pfizer Recent Developments and Future Plans
    Table 95. Eli Lilly Company Information, Head Office, and Major Competitors
    Table 96. Eli Lilly Major Business
    Table 97. Eli Lilly Covid-19 Treatment Product and Solutions
    Table 98. Eli Lilly Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 99. Eli Lilly Recent Developments and Future Plans
    Table 100. Global Covid-19 Treatment Revenue (USD Million) by Players (2018-2023)
    Table 101. Global Covid-19 Treatment Revenue Share by Players (2018-2023)
    Table 102. Breakdown of Covid-19 Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 103. Market Position of Players in Covid-19 Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 104. Head Office of Key Covid-19 Treatment Players
    Table 105. Covid-19 Treatment Market: Company Product Type Footprint
    Table 106. Covid-19 Treatment Market: Company Product Application Footprint
    Table 107. Covid-19 Treatment New Market Entrants and Barriers to Market Entry
    Table 108. Covid-19 Treatment Mergers, Acquisition, Agreements, and Collaborations
    Table 109. Global Covid-19 Treatment Consumption Value (USD Million) by Type (2018-2023)
    Table 110. Global Covid-19 Treatment Consumption Value Share by Type (2018-2023)
    Table 111. Global Covid-19 Treatment Consumption Value Forecast by Type (2024-2029)
    Table 112. Global Covid-19 Treatment Consumption Value by End User (2018-2023)
    Table 113. Global Covid-19 Treatment Consumption Value Forecast by End User (2024-2029)
    Table 114. North America Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 115. North America Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 116. North America Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
    Table 117. North America Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
    Table 118. North America Covid-19 Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 119. North America Covid-19 Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 120. Europe Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 121. Europe Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 122. Europe Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
    Table 123. Europe Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
    Table 124. Europe Covid-19 Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 125. Europe Covid-19 Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 126. Asia-Pacific Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 127. Asia-Pacific Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 128. Asia-Pacific Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
    Table 129. Asia-Pacific Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
    Table 130. Asia-Pacific Covid-19 Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 131. Asia-Pacific Covid-19 Treatment Consumption Value by Region (2024-2029) & (USD Million)
    Table 132. South America Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 133. South America Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 134. South America Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
    Table 135. South America Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
    Table 136. South America Covid-19 Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 137. South America Covid-19 Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 138. Middle East & Africa Covid-19 Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 139. Middle East & Africa Covid-19 Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 140. Middle East & Africa Covid-19 Treatment Consumption Value by End User (2018-2023) & (USD Million)
    Table 141. Middle East & Africa Covid-19 Treatment Consumption Value by End User (2024-2029) & (USD Million)
    Table 142. Middle East & Africa Covid-19 Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 143. Middle East & Africa Covid-19 Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 144. Covid-19 Treatment Raw Material
    Table 145. Key Suppliers of Covid-19 Treatment Raw Materials
List of Figures
    Figure 1. Covid-19 Treatment Picture
    Figure 2. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Covid-19 Treatment Consumption Value Market Share by Type in 2022
    Figure 4. Life Support
    Figure 5. Antiviral Medicine
    Figure 6. Antibody Treatments
    Figure 7. Others
    Figure 8. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Covid-19 Treatment Consumption Value Market Share by End User in 2022
    Figure 10. Children Picture
    Figure 11. Adult Picture
    Figure 12. Global Covid-19 Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Covid-19 Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Covid-19 Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Covid-19 Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Covid-19 Treatment Consumption Value Market Share by Region in 2022
    Figure 17. North America Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Covid-19 Treatment Revenue Share by Players in 2022
    Figure 23. Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Covid-19 Treatment Market Share in 2022
    Figure 25. Global Top 6 Players Covid-19 Treatment Market Share in 2022
    Figure 26. Global Covid-19 Treatment Consumption Value Share by Type (2018-2023)
    Figure 27. Global Covid-19 Treatment Market Share Forecast by Type (2024-2029)
    Figure 28. Global Covid-19 Treatment Consumption Value Share by End User (2018-2023)
    Figure 29. Global Covid-19 Treatment Market Share Forecast by End User (2024-2029)
    Figure 30. North America Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
    Figure 32. North America Covid-19 Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
    Figure 38. Europe Covid-19 Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
    Figure 46. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
    Figure 55. South America Covid-19 Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by End User (2018-2029)
    Figure 60. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Covid-19 Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 64. Covid-19 Treatment Market Drivers
    Figure 65. Covid-19 Treatment Market Restraints
    Figure 66. Covid-19 Treatment Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Covid-19 Treatment in 2022
    Figure 69. Manufacturing Process Analysis of Covid-19 Treatment
    Figure 70. Covid-19 Treatment Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Covid-19 Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Covid-19 Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Covid-19 Treatment market size was valued at USD 14310 million in 2023 and is forecast to a readjusted size of USD 41 million by 2030 with a CAGR of -56.8% during review period.

Product Tags

Covid-19 Treatment

Covid-19 Treatment Medicine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>